Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes.
A finding commonly observed in human immunodeficiency virus type 1 (HIV-1)-infected patients is invasion of the brain by activated T cells and infected macrophages, eventually leading to the development of neurological disorders and HIV-1-associated dementia. The recruitment of T cells and macrophages into the brain is likely the result of chemokine expression. Indeed, earlier studies revealed that levels of different chemokines were increased in the cerebrospinal fluid of HIV-1-infected patients whereas possible triggers and cellular sources for chemokine expression in the brain remain widely undefined. As previous studies indicated that HIV-1 Tat, the retroviral transactivator, is capable of inducing a variety of cellular genes, we investigated its capacity to induce production of chemokines in astrocytes. Herein, we demonstrate that HIV-1 Tat(72aa) is a potent inducer of MCP-1, interleukin-8 (IL-8), and IP-10 expression in astrocytes. Levels of induced IP-10 protein were sufficiently high to induce chemotaxis of peripheral blood lymphocytes. In addition, Tat(72aa) induced IL-8 expression in astrocytes. IL-8 mRNA induction was seen less then 1 h after Tat(72aa) stimulation, and levels remained elevated for up to 24 h, leading to IL-8 protein production. Tat(72aa)-mediated MCP-1 and IL-8 mRNA induction was susceptible to inhibition by the MEK1/2 inhibitor UO126 but was only modestly decreased by the inclusion of the p38 mitogen-activated protein kinase (MAPK) inhibitor SB202190. In contrast, Tat-mediated IP-10 mRNA induction was suppressed by SB202190 but not by the MEK1/2 inhibitor UO126. These findings indicate that MAPKs play a major role in Tat(72aa)-mediated chemokine induction in astrocytes.
Kutsch
O
O
Department of Cell Biology, The University of Alabama at Birmingham, Birmingham, Alabama 35294-0005, USA.
Oh
J
J
Nath
A
A
Benveniste
E N
EN
D001253:Astrocytes / Q000378:metabolism* / Q000821:virology*; D002478:Cells, Cultured; D018932:Chemokine CCL2 / Q000378:metabolism*; D015696:Gene Products, tat / Q000378:metabolism*; D015658:HIV Infections / Q000378:metabolism*; D015497:HIV-1; D006801:Humans; D016209:Interleukin-8 / Q000378:metabolism*; D019707:Receptors, Chemokine / Q000378:metabolism*; D054322:tat Gene Products, Human Immunodeficiency Virus
D018932:Chemokine CCL2; D015696:Gene Products, tat; D016209:Interleukin-8; D019707:Receptors, Chemokine; D054322:tat Gene Products, Human Immunodeficiency Virus